CRON
Cronos Group Inc. Common Share
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Best Pharmaceutical Stocks 2026 →
CRON Stock Analysis: Buy, Sell, or Hold?
$3.41
-0.04 (-1.16%)
▼
5d:
-8.33%
30d:
+7.91%
90d:
+8.6%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect CRON Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (56%)
Quality Score
55/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$3.21 – $3.47
Position: SLIGHTLY HIGH
Forward P/E & Valuation
13.5x
CHEAP
vs 20.2x historical avg
Wall Street Target
$2.96
-13.2% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.27 / $3.91
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: CRON shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 10, 2026 at $3.42 · last confirmed Nov 11, 2026
Strength: 7.0/10
Get Alerted When CRON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.35
Based on 0.9% avg growth
INTRINSIC VALUE TODAY
$3.32
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CRON is currently trading at $3.41, which is considered slightly high relative to its 30-day fair value range of $3.21 to $3.47. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.4) compared to its historical average (20.2). Remarkably, the market is currently pricing in an annual earnings decline of 12.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CRON is in a strong uptrend. Immediate support is located at $3.27, while resistance sits at $3.91.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $2.96. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRON is in a strong uptrend. Immediate support is located at $3.27, while resistance sits at $3.91.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $2.96. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.21 -
$3.47
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.7%
Trading Range & Key Levels
30-Day Trading Range
$3.21 -
$3.47
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$3.27
Resistance Level
$3.91
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding CRON? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 13.2% above Wall St target ($2.96)
- NEUTRAL: Bottoming setup forming (47/100) — watch for confirmation
- CAUTION: 5-day price weakness (-8.3%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
13.45
Wall Street Target
$2.96
(-13.2%)
Revenue Growth (YoY)
74.6%
Earnings Growth (YoY)
-41.0%
Profit Margin
28.0%
Valuation Discount vs History
-12.7% cheaper
PE vs Historical
13.5 vs 20.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-12.7%
(market-implied from PE analysis)
1-Year Target
$3.07
(-10%)
2-Year Target
$2.76
(-19%)
3-Year Target
$2.49
(-27%)
3-Yr Target (if PE normalizes)
(PE: 13→20)
$3.73
(+10%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -2.2%)
$4.72
(+38%)
Base:
(SPY PE: 13.4, Growth: -2.2%)
$3.19
(-6%)
Bear:
(PE: 11.4, Growth: -2.2%)
$2.71
(-20%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 21.56 | Current EPS (TTM): $0.16
Bull Case
$6.02
(+76%)
Analyst growth 58.5%, PE expands to 23.7
Base Case
$5.47
(+60%)
Market implied 58.5%, PE stable at 21.6
Bear Case
$2.35
(-31%)
Severe decline -20.0%, PE contracts to 18.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.4 to 20.2
Stabilization Target:
$5.12
(+50.2%)
PE Expansion Potential:
+50.2%
Share CRON Analysis
Share this live CRON analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CRON)
Bearish
3 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Trader with a large following on StockTwits expresses bullish sentiment towards $CRON by disclosing a significant position in the stock and calls. No newsworthy articles were found.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:57 AM ET
Data refreshes hourly during market hours. Next update: 5:57 AM
Data refreshes hourly during market hours. Next update: 5:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 60 BUY |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
Advanced CRON Option Strategies
Professional options setups generated by AI based on today's CRON price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CRON Research Pages
